openPR Logo
Press release

Anti-radiation Drugs Market Projected to Reach US$ 9.6 Billion by 2031, Exhibiting a Significant 9.9% CAGR

02-06-2024 02:10 PM CET | Health & Medicine

Press release from: Transparency Market Research

Anti-radiation Drugs Market

Anti-radiation Drugs Market

The global anti-radiation drugs market was valued at US$ 3.4 billion in 2021 and is anticipated to grow at a CAGR of 9.9% from 2022 to 2031. This growth is driven by the increasing demand for medications that prevent the concentration and absorption of radioactive iodide in the human thyroid gland, such as Prussian Blue, Diethylenetriamine pentaacetate (DTPA), and potassium iodide (KI).

Increased demand: Growing need for medications to prevent the concentration and absorption of radioactive iodide in the human thyroid gland is a primary driver of market growth.

Nuclear proliferation: Escalating concerns regarding potential nuclear catastrophes due to the proliferation of nuclear weapons and warheads globally are spurring nations to intensify efforts in developing radiation countermeasures.

Get a Sample Copy of the Anti-radiation Drugs Market Research Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85240&utm_source=OpenPR_Ajay&utm_medium=OpenPR

Key Findings:

Increase in Acute Radiation Syndrome Prevalence: The acute radiation syndrome (ARS) segment dominated the industry in 2021. ARS is a critical factor in public health and welfare in radiological or nuclear incidents.

Growing Need for Potassium Iodide Products: Potassium iodide (KI) segment led the global market in 2021. KI compounds are highly effective in protecting against harmful radiations and are widely used in the radiopharmaceuticals sector.

Companies Profiled: Key players include Amgen Inc., Anbex Inc., Arco Pharmaceuticals LLC, BTG International Inc., Cellphire, Inc., among others.

Market Segmentation:

Compound: Potassium Iodide (KI), Prussian Blue, DTPA (Diethylenetriamine Pentaacetate), Others

Application: Acute Radiation Syndrome (ARS), Cancer Treatment, Radiation Exposure, Others

Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Others

Geographical Coverage:

North America: United States, Canada, Mexico

Europe: Germany, UK, France, Italy, Russia, Turkey, etc.

Asia-Pacific: China, Japan, Korea, India, Australia, Southeast Asia

South America: Brazil, etc.

Middle East and Africa: North Africa, GCC Countries

Key Features of the Report:

Competitive Developments: Expansions, deployments, new product launches, and market acquisitions.

Market Opportunities: Identification of higher growth segments for stakeholders.

Global Industry Analysis: In-depth examination of key regions and SWOT analysis.

Strategic Recommendations: Insights for incumbents and new entrants to gain a competitive advantage.

Comprehensive Analysis: Key product segments, application spectrum, and market dynamics are analyzed.

Inquire more about this report before purchase - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=85240&utm_source=OpenPR_Ajay&utm_medium=OpenPR

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Anti-radiation Drugs Market Projected to Reach US$ 9.6 Billion by 2031, Exhibiting a Significant 9.9% CAGR here

News-ID: 3374459 • Views:

More Releases from Transparency Market Research

Global SiC Ceramics Market Poised for Robust Growth, Projected to Reach USD 3.1 Billion by 2035 | Transparency Market Research
Global SiC Ceramics Market Poised for Robust Growth, Projected to Reach USD 3.1 …
The global silicon carbide (SiC) ceramics market continues to demonstrate strong growth potential, underpinned by accelerating demand from advanced industrial and electronic applications. Valued at US$ 1.8 Billion in 2024, the market is projected to reach US$ 3.1 Billion by 2035, expanding at a compound annual growth rate (CAGR) of 5.2% during the forecast period from 2025 to 2035. This steady expansion reflects the increasing importance of SiC ceramics as
Furfuryl Alcohol Market to Reach USD 1.34 Billion by 2035, Supported by Rising Demand for Bio-Based Chemicals and Expanding Foundry Industry | TMR
Furfuryl Alcohol Market to Reach USD 1.34 Billion by 2035, Supported by Rising D …
The global Furfuryl Alcohol Market was valued at US$ 624.3 million in 2024 and is projected to reach US$ 1,341.2 million by 2035, expanding at a compound annual growth rate (CAGR) of 7.2% from 2025 to 2035. This growth is primarily driven by the rising demand for bio-based and sustainable chemicals, along with the steady expansion of the foundry and metal casting industry, particularly across emerging economies in Asia Pacific. Gain a
Air-Entraining Agents Market Outlook 2035: Forecast to Reach US$ 2.48 Billion by 2035 at a CAGR of 3.5% Driven by Infrastructure Expansion and Climate-Resilient Concrete Demand
Air-Entraining Agents Market Outlook 2035: Forecast to Reach US$ 2.48 Billion by …
The global Air-Entraining Agents (AEAs) Market was valued at US$ 1.70 billion in 2024 and is projected to reach US$ 2.48 billion by 2035, expanding at a compound annual growth rate (CAGR) of 3.5% from 2025 to 2035. This steady growth trajectory reflects the essential role AEAs play in modern concrete formulations, particularly in infrastructure projects that demand long-term durability, freeze-thaw resistance, and improved workability. Despite being a mature segment within
A2P SMS Market Outlook 2035: Expanding from US$ 71.2 Bn in 2024 to US$ 117.0 Bn by 2035 at a CAGR of 4.2%
A2P SMS Market Outlook 2035: Expanding from US$ 71.2 Bn in 2024 to US$ 117.0 Bn …
The global Application-to-Person (A2P) SMS market is entering a phase of steady and resilient expansion, driven by the growing need for secure, reliable, and real-time communication between enterprises and consumers. Valued at US$ 71.2 Bn in 2024, the market is projected to reach US$ 117.0 Bn by 2035, expanding at a CAGR of 4.2% from 2025 to 2035. Despite the rise of internet-based messaging platforms, A2P SMS continues to maintain

All 5 Releases


More Releases for Drugs

Generic Drugs Market Application Anti-Infective Drugs, Anti-Arthritis Drugs, Ant …
Generic drugs are the medications that are developed to be similar to a medicine that is already commercially available in the market with a brand name. The generic drug is similar to the medicine available in terms of dosage, safety and strength, mode of administration, quality and intended use. Due to the similarities, generic drugs are capable of treating various diseases. Generic drugs are most cost effective than the branded
Cytotoxic Drugs Market Growing Demand for Antimetabolite Drugs
According to Precision Business Insights (PBI), the latest report, the cytotoxic drugs market is expected to be valued at USD 15,927.2 million in 2022 and is poised to grow at a significant CAGR of 2.2% over 2022-2028. The primary drivers of the expansion of the global cytotoxic drugs market include the increasing prevalence of cancer diseases, the increasing use and approval of cytotoxic drugs, and the increasing consumption of alcohol
Global Antithrombotic Drugs Market | Global Antithrombotic Drugs Industry | Glob …
Antithrombotic drugs are special drugs that help to prevent the formation of thrombus or clot. These drugs are used to reduce the formation of blood clots by reducing the capability of body to form a blood clot. Antithrombotic drugs act by preventing the production of vitamin K in the liver. Anticoagulant, antiplatelet, and thrombolytic agents are different types of antithrombotic agents that act by different clotting processes. Arterial & venous
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication
Hepatitis Drugs Market by Therapeutics, Diagnostics, Patient, Drugs Policy
The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market. Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/hepatitis-drugs-market Among the various types, the hepatitis C segment is expected to be the largest segment, and expected to witness the fastest
Epilepsy Drugs Market by Country, Drugs, Company & Forecast
For More Information: https://renub-research.blogspot.com/2019/04/the-factors-that-are-driving-global.html Epilepsy is a chronic disease in which patient’s brain activities become abnormal due to seizures. Seizure is an unexpected rush of electrical activity in the brain. Seizure is categorized by two types - generalized seizures and focal or partial seizures. Generalized seizures affect the whole brain whereas focal or partial seizures affect just one part of the brain. Global epilepsy drugs market is expected to cross US$